Identifying and targeting new cancer drivers
Systematic Characterization and Targeting of Neomorphic Drivers in Cancer
This study is looking at specific changes in genes that can affect how certain cancers, like glioma, sarcoma, and endometrial cancer, grow and respond to treatment, with the hope of finding better ways to help patients fight these diseases.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10931653 on NIH RePORTER |
What this research studies
This research focuses on understanding and targeting neomorphic drivers in various cancers, including glioma, sarcoma, and endometrial cancers. By utilizing advanced computational and experimental methods, the project aims to characterize mutations and fusion genes that alter tumor behavior and response to treatment. The goal is to identify biomarkers that can predict how these changes affect cancer progression and treatment outcomes, ultimately leading to more effective therapies for patients. The research will explore the functional consequences of these genetic alterations to improve cancer treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioma, sarcoma, or endometrial cancers who have specific mutations or fusion genes.
Not a fit: Patients with cancers not included in the study, or those without identifiable neomorphic drivers, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments by targeting specific genetic alterations in tumors.
How similar studies have performed: Other research has shown promise in targeting genetic alterations in cancer, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Mills, Gordon B. — Oregon Health & Science University
- Study coordinator: Mills, Gordon B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.